COMPANY
RICOVR Healthcare Inc.
NIH awards 3
- NIH award 3R43DA059318-01S1 FY2025: $54,382 awarded for that fiscal year; activity R43 (SBIR); PI SEIMETZ, JOSEPH; recipient as written: RICOVR HEALTHCARE INC., PRINCETON, NJ. Advancement of a Point-of-Need (PoN) pla source ↗
- NIH award 1R43HL172410-01 FY2024: $295,895 awarded for that fiscal year; activity R43 (SBIR); PI SEIMETZ, JOSEPH; recipient as written: RICOVR HEALTHCARE INC., PRINCETON, NJ. Quantitative measurement of PlGF using a source ↗
- NIH award 1R43DA059318-01 FY2024: $295,606 awarded for that fiscal year; activity R43 (SBIR); PI SEIMETZ, JOSEPH; recipient as written: RICOVR HEALTHCARE INC., PRINCETON, NJ. Advancement of a Point-of-Need (PoN) plat source ↗
Funding and NIH signals
- SEC Form D raise Raised $550K (Form D filed Jan 20, 2026). SEC Form D 0001800521-26-000003 (Jan 20, 2026)
Evidence (1 event)
- Jan 20, 2026 · SEC Form D 0001800521-26-000003
Name of Issuer: Ricovr Healthcare Inc.; CIK: 1800521; Address: Princeton, NJ; Submission type: D; Filing date: 2026-01-20; Industry Group: Other Health Care; Date of First Sale: 2025-12-19; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 550000; Federal exemptions: 06b
- Jan 20, 2026 · SEC Form D 0001800521-26-000003